| LBPEE46 | Identifying high risk populations for targeted testing and rapid treatment response from a COVID-19 screening and testing cohort in South Africa: An observational data analysis | E-poster | E49 |
| LBPEE47 | Telehealth for the continuation of same-day antiretroviral therapy during the COVID-19 outbreak and beyond | E-poster | E57 |
| LBPEF57 | Advancing ethical HIV/co-infections research in pregnancy: Guidance from the PHASES Working Group | E-poster | F47 |
| LBPEF58 | The Affordable Care Act and HIV pre-exposure prophylaxis: Regional disparities in qualified health plan coverage and prior authorization requirements, 2018-2020 | E-poster | F7 |
| LBPEF59 | Criminalization of consensual sex between men associated with poor access to HIV-services for gay, bisexual and other men who have sex with men worldwide: Findings from GMHR 2019-2020 | E-poster | F7 |
| LBPEF60 | Home-based ARV delivery during COVID-19: From policy to practice in Jakarta, Indonesia | E-poster | F48 |
| LBPEF61 | Biopolitics and governmentality in the age of CoVID-19: Biological citizenship (or lack thereof) of key populations in the response against HIV, HepC & other STIs during a national lockdown | E-poster | F27 |
| PEA0001 | Evolutionary genetics of HIV-1 strain causing infection in different cohort of people living with HIV in Nepal | E-poster | A1 |
| PEA0002 | Prevalence of drug resistance mutations among HIV positive individuals with low level viremia on antiretroviral therapy in Botswana | E-poster | A1 |
| PEA0003 | Impact of human immunodeficiency virus type 1 subtype C (HIV-1C) transmitted/founder (T/F) viruses tat genetic variation on transactivation activity and disease outcome | E-poster | A1 |